You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cc-99282

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Boston, Massachusetts
  • +17 more
Aug 1, 2022

Lymphoma, B-Cell Trial in Worldwide (CC-220, Rituximab, Cyclophosphamide)

Recruiting
  • Lymphoma, B-Cell
  • Scottsdale, Arizona
  • +26 more
Jul 1, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • JCAR017
  • +7 more
  • Duarte, California
  • +17 more
Jan 13, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • CC-99282
  • +4 more
  • Los Angeles, California
  • +86 more
Jan 23, 2023